Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Arrhythmias

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 103 articles: HTML format

Single Articles

September 2025
1. HAIMOVICH JS, Kany S, Ajufo E, Andrade JG, et al
   Outcomes and Management of Stressor-Associated Atrial Fibrillation: JACC State-of-the-Art Review.
   J Am Coll Cardiol. 2025;86:910-939.
   PubMed     Abstract available
   
   
   
2. CORDERO A, de la Espriella R, Nunez J
   Heart Failure Biomarkers for Atrial Fibrillation Prediction: Why Not CA125?
   J Am Coll Cardiol. 2025;86:e103-e104.
   PubMed    
   
   
   
3. JURGENS SJ, Melloni GEM, Kany S, Fabritz L, et al
   Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial Participants.
   J Am Coll Cardiol. 2025;86:738-753.
   PubMed     Abstract available
   
   
   
4. HAMMERSLEY DJ, McDonagh TA, Prasad SK
   Bridging the Gap Between Atrial Fibrillation, Cardiomyopathy and Prognosis: Does Genetics Hold the Key?
   J Am Coll Cardiol. 2025;86:754-756.
   PubMed    
   
   
   August 2025
5. CHOW CLD, Wong C, Sutherland N, Obeyesekere MN, et al
   Clinical Outcomes of Conduction System Pacing vs Right Ventricular Septal Pacing in Atrioventricular Block: The CSPACE Randomized Controlled Trial.
   J Am Coll Cardiol. 2025;86:563-573.
   PubMed     Abstract available
   
   
   
6. PARKASH R, Ellenbogen KA
   Mounting Evidence for Conduction System Pacing in Atrioventricular Block Ushers in a New Era.
   J Am Coll Cardiol. 2025;86:574-576.
   PubMed    
   
   
   
7. WEE SB, Kang DY, Cho MS, Kim MJ, et al
   Long-Term Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior PCI: Insights From EPIC-CAD Trial.
   J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07258.
   PubMed    
   
   
   
8. NICOLAU AM, Giugliano RP, Zimerman A, Afilalo J, et al
   Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF Substudy.
   J Am Coll Cardiol. 2025;86:426-439.
   PubMed     Abstract available
   
   
   
9. ROMITI GF, Lip GYH
   Switching Anticoagulants and Managing Complexity in Frail Patients With Atrial Fibrillation: An Integrated Approach.
   J Am Coll Cardiol. 2025;86:440-443.
   PubMed    
   
   
   
10. BALAKRISHNAN I, Salbinski L, Nozica N, Andrews E, et al
    Atrial Fibrillation and Systemic Embolic Events in Patients With LMNA Cardiomyopathy.
    J Am Coll Cardiol. 2025;86:404-407.
    PubMed    
    
    
    July 2025
11. CHI KY, Chang Y, Lee PL, Rossi R, et al
    Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage: A Meta-Analysis of Randomized Trials.
    J Am Coll Cardiol. 2025;86:287-290.
    PubMed    
    
    
    
12. GALEA R, De Marco F, Aminian A, Meneveau N, et al
    3-Year Clinical Outcomes Comparing the Amulet vs Watchman FLX for Left Atrial Appendage Closure in Patients With Atrial Fibrillation: Results From the SWISS-APERO Randomized Clinical Trial.
    J Am Coll Cardiol. 2025;86:3-14.
    PubMed     Abstract available
    
    
    
13. OSMANCIK P, Roubicek T, Havranek S, Chovancik J, et al
    Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs to Treat Atrial Fibrillation: PRAGUE-25 Trial.
    J Am Coll Cardiol. 2025;86:18-28.
    PubMed     Abstract available
    
    
    
14. WEISS R, Sleiman Morales J
    Has the Time Come to Stop Performing Routine Defibrillation Testing for Subcutaneous Implantable Cardioverter Defibrillators?
    J Am Coll Cardiol. 2025;86:46-48.
    PubMed    
    
    
    
15. KERKOURI F, Eschalier R, Fareh S, Marquie C, et al
    Defibrillation Testing During Implantation of Subcutaneous Implantable Cardioverter Defibrillators.
    J Am Coll Cardiol. 2025;86:32-45.
    PubMed     Abstract available
    
    
    June 2025
16. PATEL SM, Giugliano RP, Morrow DA, Parkar S, et al
    Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71.
    J Am Coll Cardiol. 2025;85:2288-2298.
    PubMed     Abstract available
    
    
    May 2025
17. KIMURA Y, Wallet J, Brouwer C, Bokma JP, et al
    Proactive Mapping and Preventive Ablation Reduce Defibrillator Implantation Rates in Tetralogy of Fallot.
    J Am Coll Cardiol. 2025;85:1695-1705.
    PubMed     Abstract available
    
    
    
18. REDDY VY, Gerstenfeld EP, Schmidt B, Nair D, et al
    Pulsed Field Ablation for Persistent Atrial Fibrillation: 1-Year Results of ADVANTAGE AF.
    J Am Coll Cardiol. 2025;85:1664-1678.
    PubMed     Abstract available
    
    
    
19. PABON MA, Filippatos G, Claggett BL, Miao MZ, et al
    Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled Analysis.
    J Am Coll Cardiol. 2025;85:1649-1660.
    PubMed     Abstract available
    
    
    
20. AHMAD A, Doshi RN
    Pulse Field Ablation for Persistent Atrial Fibrillation: Does Posterior Wall Isolation Improve Outcomes?
    J Am Coll Cardiol. 2025;85:1679-1681.
    PubMed    
    
    
    March 2025
21. WALLENTIN L, Lindback J, Hijazi Z, Oldgren J, et al
    Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2025;85:1173-1185.
    PubMed     Abstract available
    
    
    
22. IBANEZ CRIADO JL, Ortiz M, Garcia-Fernandez J, Martinez-Alday JD, et al
    Can ICD Electrograms Help Ventricular Tachycardia Ablation?: Results From the Multicenter Randomized AIDEG-VTA Trial.
    J Am Coll Cardiol. 2025;85:1124-1137.
    PubMed     Abstract available
    
    
    
23. SHURRAB M, Ko DT
    Fewer Drugs, Less Bleeding in Atrial Fibrillation With Stable Coronary Artery Disease: Less Is More.
    J Am Coll Cardiol. 2025;85:1204-1206.
    PubMed    
    
    
    
24. MCINTYRE WF, Katsanos AH
    Biomarker-Based Stroke Risk Assessment in Atrial Fibrillation: Is the Time Ripe?
    J Am Coll Cardiol. 2025;85:1186-1188.
    PubMed    
    
    
    
25. GRONDIN S, Neveu B, Soltani I, Alaoui AA, et al
    Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases: A 14-Year Retrospective Study.
    J Am Coll Cardiol. 2025;85:988-999.
    PubMed     Abstract available
    
    
    February 2025
26. OLTMAN CG, Kim TP, Lee JWY, Lupu JD, et al
    Expanding the Dialogue on Atrial Fibrillation in the United States.
    J Am Coll Cardiol. 2025;85:e61.
    PubMed    
    
    
    January 2025
27. TANNU M, Lopes RD, Wojdyla DM, Goodman SG, et al
    Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation: Insights From AUGUSTUS.
    J Am Coll Cardiol. 2025 Jan 24:S0735-1097(24)10555.
    PubMed     Abstract available
    
    
    
28. RASHEDI S, Keykhaei M, Sato A, Steg PG, et al
    Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials.
    J Am Coll Cardiol. 2025 Jan 17:S0735-1097(25)00071.
    PubMed     Abstract available
    
    
    
29. RUSSO AM, Desai MY, Do MM, Butler J, et al
    ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing.
    J Am Coll Cardiol. 2025 Jan 7:S0735-1097(24)10510.
    PubMed    
    
    
    November 2024
30. BREEMAN KTN, Tjong FVY, Miller MA, Neuzil P, et al
    Ten Years of Leadless Cardiac Pacing.
    J Am Coll Cardiol. 2024;84:2131-2147.
    PubMed     Abstract available
    
    
    
31. O'LEARY ET, Feins EN, Davee J, Baird CW, et al
    Intraoperative Conduction Mapping to Reduce Postoperative Atrioventricular Block in Complex Congenital Heart Disease.
    J Am Coll Cardiol. 2024;84:2102-2112.
    PubMed     Abstract available
    
    
    
32. KUKAVICA D, Trancuccio A, Mazzanti A, Napolitano C, et al
    Nonmodifiable Risk Factors Predict Outcomes in Brugada Syndrome.
    J Am Coll Cardiol. 2024;84:2087-2098.
    PubMed     Abstract available
    
    
    
33. LAKKIREDDY D, Ellis CR, Thaler D, Swarup V, et al
    5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial.
    J Am Coll Cardiol. 2024 Nov 15:S0735-1097(24)10313.
    PubMed     Abstract available
    
    
    
34. RAMIREDDY A, Braunstein ED, Chugh SS
    Adding AI to the Toolkit for Patients With Implantable Cardioverter-Defibrillators.
    J Am Coll Cardiol. 2024 Nov 13:S0735-1097(24)09962.
    PubMed    
    
    
    October 2024
35. ROSMAN L, Lampert R, Wang K, Gehi AK, et al
    Machine Learning-Based Prediction of Death and Hospitalization in Patients With Implantable Cardioverter Defibrillators.
    J Am Coll Cardiol. 2024 Oct 15:S0735-1097(24)08455.
    PubMed     Abstract available
    
    
    
36. IKENOUCHI T, Nitta J, Inaba O, Negishi M, et al
    Embryological Classification of Arrhythmogenic Triggers Initiating Atrial Fibrillation.
    J Am Coll Cardiol. 2024 Oct 14:S0735-1097(24)08391.
    PubMed     Abstract available
    
    
    
37. WOLFE NK, Schiff MD, Olivieri LJ, Christopher AB, et al
    Cardiac MRI Predictors of Arrhythmic Sudden Cardiac Events in Patients With Fontan Circulation.
    J Am Coll Cardiol. 2024 Oct 14:S0735-1097(24)08394.
    PubMed     Abstract available
    
    
    
38. SELVANAYAGAM JB, Muser D, Nucifora G
    The Pursuit of Improved Arrhythmic Risk Stratification in Nonischemic Cardiomyopathy: Are We Getting Any Closer?
    J Am Coll Cardiol. 2024;84:1421-1423.
    PubMed    
    
    
    
39. VARGA CR, Cleland JGF, Abraham WT, Lip GYH, et al
    Implantable Cardioverter Defibrillator and Resynchronization Therapy in Patients With Overt Chronic Kidney Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;84:1342-1362.
    PubMed     Abstract available
    
    
    September 2024
40. BARNES GD, Lip GYH
    Applying Clinical Risk Scores in Real-World Practice: The CHA(2)DS(2)-VASc Score in Atrial Fibrillation.
    J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08169.
    PubMed    
    
    
    
41. KIM YG, Lee HS, Kim H, Choi JI, et al
    Reply: The Association of Bradycardic Event Risk With Antiarrhythmic Drugs for Atrial Fibrillation.
    J Am Coll Cardiol. 2024;84:e81.
    PubMed    
    
    
    
42. REIFFEL JA
    The Association of Bradycardic Event Risk With Antiarrhythmic Drugs for Atrial Fibrillation.
    J Am Coll Cardiol. 2024;84:e79.
    PubMed    
    
    
    
43. DESHMUKH A, Agarwal S, DeSimone CV
    The Alarming Surge of Atrial Fibrillation in the United States.
    J Am Coll Cardiol. 2024 Sep 5:S0735-1097(24)08158.
    PubMed    
    
    
    
44. BERGONTI M, Ciconte G, Cruzalegui Gomez J, Crotti L, et al
    Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome.
    J Am Coll Cardiol. 2024;84:921-933.
    PubMed     Abstract available
    
    
    
45. KATAPADI A, Lakkireddy D
    The Post-Left Atrial Appendage Occlusion Antithrombotic Selection Conundrum: Are We There Yet?
    J Am Coll Cardiol. 2024;84:901-903.
    PubMed    
    
    
    
46. REINHARDT SW, Gibson DN, Hsu JC, Kapadia SR, et al
    Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion.
    J Am Coll Cardiol. 2024;84:889-900.
    PubMed     Abstract available
    
    
    
47. YANG E, Bhatt DL, Atwater B
    Bleeding and Thrombosis in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2024;84:886-888.
    PubMed    
    
    
    
48. BERWANGER O, Wojdyla DM, Fanaroff AC, Budaj A, et al
    Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-Way Comparison From AUGUSTUS.
    J Am Coll Cardiol. 2024;84:875-885.
    PubMed     Abstract available
    
    
    August 2024
49. LOPES RD, Atlas SJ, Go AS, Lubitz SA, et al
    Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention.
    J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08174.
    PubMed     Abstract available
    
    
    
50. VERMA S, Butler J, Borlaug BA, Davies MJ, et al
    Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Program.
    J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08195.
    PubMed     Abstract available
    
    
    
51. HAMMERSLEY DJ, Zegard A, Androulakis E, Jones RE, et al
    Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients With Nonischemic Cardiomyopathy.
    J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08109.
    PubMed     Abstract available
    
    
    
52. MEWTON N, Zores F, Packer M
    Catheter Ablation for Atrial Fibrillation in Advanced Heart Failure: Can We Trust the CASTLE-HTx Trial?
    J Am Coll Cardiol. 2024;84:862-864.
    PubMed    
    
    
    
53. HALLER PM, Jarolim P, Palazzolo MG, Bellavia A, et al
    Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF.
    J Am Coll Cardiol. 2024 Aug 19:S0735-1097(24)07965.
    PubMed     Abstract available
    
    
    
54. NOUBIAP JJ, Tang JJ, Teraoka JT, Dewland TA, et al
    Minimum National Prevalence of Diagnosed Atrial Fibrillation Inferred From California Acute Care Facilities.
    J Am Coll Cardiol. 2024 Aug 19:S0735-1097(24)07903.
    PubMed     Abstract available
    
    
    
55. ITZHAKI BEN ZADOK O, Cuddy SAM, Gaggin HK, Clerc OF, et al
    Safety of Direct Current Cardioversion Without Routine Transesophageal Echocardiography in Patients With Cardiac Amyloidosis.
    J Am Coll Cardiol. 2024;84:675-677.
    PubMed    
    
    
    
56. HUMMEL J, Houmsse M, Tomassoni G, Nair D, et al
    A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest.
    J Am Coll Cardiol. 2024;84:525-536.
    PubMed     Abstract available
    
    
    July 2024
57. SHAH SJ
    Anticoagulants in Subclinical Atrial Fibrillation: Beginning to Define the Treatment Paradigm.
    J Am Coll Cardiol. 2024;84:365-367.
    PubMed    
    
    
    
58. LOPES RD, Granger CB, Wojdyla DM, McIntyre WF, et al
    Apixaban vs Aspirin According to CHA(2)DS(2)-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA.
    J Am Coll Cardiol. 2024;84:354-364.
    PubMed     Abstract available
    
    
    
59. HANNA P, Macias C, Buch E
    ALARA in Atrial Fibrillation: Redefining Ablation Success.
    J Am Coll Cardiol. 2024;84:75-77.
    PubMed    
    
    
    June 2024
60. SHOURESHI P, Tan AY, Koneru J, Ellenbogen KA, et al
    Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:2214-2232.
    PubMed     Abstract available
    
    
    May 2024
61. MCCAULEY MD, Iacobellis G, Li N, Nattel S, et al
    Targeting the Substrate for Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:2015-2027.
    PubMed     Abstract available
    
    
    
62. HUNG CL, Yang NI, Chiang CE
    Cardiovascular Risk Stratification by LV Size Among AF Population: Smaller Is Not Always Better.
    J Am Coll Cardiol. 2024;83:1970-1972.
    PubMed    
    
    
    
63. LI M, Ren L, He L, Lai Y, et al
    Small Left Ventricle in Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk.
    J Am Coll Cardiol. 2024;83:1957-1969.
    PubMed     Abstract available
    
    
    
64. IP JE, Coutu B, Noseworthy PA, Parody ML, et al
    Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion.
    J Am Coll Cardiol. 2024;83:2032-2034.
    PubMed    
    
    
    
65. CHAKRAVARTY T, Solanki A, Bhardwaj N, Patel V, et al
    Anticoagulation for Atrial Fibrillation in Patients With Surgically Occluded Left Atrial Appendage.
    J Am Coll Cardiol. 2024;83:1936-1938.
    PubMed    
    
    
    
66. GORCSAN J, Eguchi S
    Predictors of Arrhythmic Outcomes in Patients With Dilated and Nondilated Left Ventricular Cardiomyopathies.
    J Am Coll Cardiol. 2024;83:1852-1854.
    PubMed    
    
    
    
67. REDDY VY, Mansour M, Calkins H, d'Avila A, et al
    Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: Recurrent Atrial Arrhythmia Burden.
    J Am Coll Cardiol. 2024 May 6:S0735-1097(24)07133.
    PubMed     Abstract available
    
    
    March 2024
68. QUINN R, Leader N, Lebovic G, Chow CM, et al
    Accuracy of Wearable Heart Rate Monitors During Exercise in Sinus Rhythm and Atrial Fibrillation.
    J Am Coll Cardiol. 2024;83:1177-1179.
    PubMed    
    
    
    
69. NINNI S, Dombrowicz D, de Winther M, Staels B, et al
    Genetic Factors Altering Immune Responses in Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1163-1176.
    PubMed     Abstract available
    
    
    
70. DIXIT S, Oranefo JU, Raad M
    Atrial Fibrillation Management With Antiarrhythmic Drug Therapy: Balancing Benefits and Bradycardia Risks.
    J Am Coll Cardiol. 2024;83:1039-1041.
    PubMed    
    
    
    
71. KIM YG, Lee HS, Kim H, Kim M, et al
    Association of Antiarrhythmic Drug Therapy With Syncope and Pacemaker Implantation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2024;83:1027-1038.
    PubMed     Abstract available
    
    
    
72. NASER JA, Alexandrino FB, Harada T, Michelena HI, et al
    The Natural History of Atrial Functional Mitral Regurgitation.
    J Am Coll Cardiol. 2024 Mar 17:S0735-1097(24)00413.
    PubMed     Abstract available
    
    
    
73. NEWMAN JD, O'Meara E, Bohm M, Savarese G, et al
    Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:932-950.
    PubMed     Abstract available
    
    
    February 2024
74. BARIANI R, Rigato I, Celeghin R, Marinas MB, et al
    Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies.
    J Am Coll Cardiol. 2024;83:797-807.
    PubMed     Abstract available
    
    
    
75. YOO JE, Kim M, Kim B, Lee H, et al
    Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury.
    J Am Coll Cardiol. 2024;83:741-751.
    PubMed     Abstract available
    
    
    
76. ANDREOTTI F, Massetti M, Montalescot G
    Thrombosis, Bleeding, and the Promise of Factor XI(a) Inhibition.
    J Am Coll Cardiol. 2024;83:679-681.
    PubMed    
    
    
    
77. EIKELBOOM JW, Mundl H, Alexander JH, Caso V, et al
    Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.
    J Am Coll Cardiol. 2024;83:669-678.
    PubMed     Abstract available
    
    
    January 2024
78. BEJJANI A, Khairani CD, Assi A, Piazza G, et al
    When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:444-465.
    PubMed     Abstract available
    
    
    
79. DI BIASE L, Lakkireddy DJ, Marazzato J, Velasco A, et al
    Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:82-108.
    PubMed     Abstract available
    
    
    December 2023
80. MULLEN CA
    Apixaban for Children With Heart Disease.
    J Am Coll Cardiol. 2023;82:2310-2311.
    PubMed    
    
    
    November 2023
81. JOGLAR JA, Chung MK, Armbruster AL, Benjamin EJ, et al
    2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2023 Nov 30:S0735-1097(23)06465.
    PubMed     Abstract available
    
    
    
82. WIGGINS BS, Cibotti-Sun M, Moore MM
    2023 Atrial Fibrillation Guideline-at-a-Glance.
    J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)07853.
    PubMed    
    
    
    
83. QIAN F, Siscovick D
    Reply: Omega-3 Fatty Acids and Atrial Fibrillation: The Importance of the Clinical Question.
    J Am Coll Cardiol. 2023;82:e207.
    PubMed    
    
    
    
84. MYHRE PL
    Omega-3 Fatty Acids and Atrial Fibrillation: The Difference Between Dietary Consumption and Supplementation.
    J Am Coll Cardiol. 2023;82:e205.
    PubMed    
    
    
    
85. CHEN H, Xu Y
    Omega-3 Fatty Acids and Atrial Fibrillation Risk: A Controversy Resolved?
    J Am Coll Cardiol. 2023;82:e203.
    PubMed    
    
    
    
86. O'KEEFE EL, Lavie CJ, Elagizi A, Milani RV, et al
    Omega 3, Atrial Fibrillation, and Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:e201-e202.
    PubMed    
    
    
    
87. SUN G, Ahlehoff O, Fosbol EL, Schou M, et al
    Long-Term Incidence of Atrial Fibrillation in Patients With Autoimmune Disease.
    J Am Coll Cardiol. 2023;82:1969-1971.
    PubMed    
    
    
    
88. LAU ES, Di Achille P, Kopparapu K, Andrews CT, et al
    Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:1936-1948.
    PubMed     Abstract available
    
    
    
89. SARNHOLM J, Ljotsson B, Braunschweig F
    Reply: Targeting Symptom Preoccupation in Atrial Fibrillation: A Promising Treatment Approach and Avenue for Future Research.
    J Am Coll Cardiol. 2023;82:e183-e184.
    PubMed    
    
    
    
90. ANDERSSON P, Coyne J
    Caution Warranted Regarding the Efficacy of iCBT in Patients With Symptomatic Paroxysmal Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:e181.
    PubMed    
    
    
    
91. WANG J, Jia R, Lu Y, Yu W, et al
    Postmenopausal Women With Atrial Fibrillation and Mental Health Symptoms: A Group Deserving Attention.
    J Am Coll Cardiol. 2023;82:e179.
    PubMed    
    
    
    
92. DESAI BOSTROM AE, Lundberg J
    Beyond the Surface: Scrutinizing Methodological Biases in a Study on iCBT for Atrial Fibrillation.
    J Am Coll Cardiol. 2023;82:e177.
    PubMed    
    
    
    October 2023
93. MARGOLIS G, Chee J, Kazatsker M, Roguin A, et al
    Etiology of Early-Onset Complete Atrioventricular Block and Use of Implanted Cardiac Electronic Devices.
    J Am Coll Cardiol. 2023;82:1804-1806.
    PubMed    
    
    
    
94. HALPERIN JL, Rothman KJ
    Initial Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion: Shifting Approaches to a Moving Target.
    J Am Coll Cardiol. 2023;82:1774-1776.
    PubMed    
    
    
    
95. KASKI JP, Norrish G
    Family Screening in Gene-Elusive Hypertrophic Cardiomyopathy: Time for a Change or Should We Tread Cautiously?
    J Am Coll Cardiol. 2023;82:1762-1764.
    PubMed    
    
    
    
96. CARVALHO PEP, Gewehr DM, Miyawaki IA, Nogueira A, et al
    Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion.
    J Am Coll Cardiol. 2023;82:1765-1773.
    PubMed     Abstract available
    
    
    
97. KRANTZ MJ, Stockbridge N, Kao DP, Klein MG, et al
    Reply: Loperamide-Associated Ventricular Arrhythmias.
    J Am Coll Cardiol. 2023;82:e159.
    PubMed    
    
    
    
98. FONT J, Alexandre J, Dolladille C, Milliez P, et al
    Loperamide-Associated Ventricular Arrhythmias.
    J Am Coll Cardiol. 2023;82:e157-e158.
    PubMed    
    
    
    
99. ARGO MB, Barron DJ, Eghtesady P, Yerebakan C, et al
    Outcomes After Hybrid Palliation for Infants With Critical Left Heart Obstruction.
    J Am Coll Cardiol. 2023;82:1427-1441.
    PubMed     Abstract available
    
    
    September 2023
100. BESSIERE F, Waldmann V, Combes N, Metton O, et al
     Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part II: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;82:1121-1130.
     PubMed     Abstract available
     
     
     
101. BESSIERE F, Waldmann V, Combes N, Metton O, et al
     Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part I: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2023;82:1108-1120.
     PubMed     Abstract available
     
     
     
102. PUJOL-LOPEZ M, Du Fay de Lavallaz J, Rangan P, Beaser A, et al
     Vasovagal Responses to Human Monomorphic Ventricular Tachycardia: Hemodynamic Implications From Sinus Rate Analysis.
     J Am Coll Cardiol. 2023;82:1096-1105.
     PubMed     Abstract available
     
     
     
103. D'AVILA A, D'Angelo RN
     Vasovagal Responses to Human Monomorphic Ventricular Tachycardia: Atropine to the Rescue.
     J Am Coll Cardiol. 2023;82:1106-1107.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.